Simulect, Neoral, Cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study.
Kumar
M S
MS
Department of Transplantation, MCP Hahnemann University, Philadelphia, Pennsylvania 19102, USA.
Kode
R K
RK
Pankewycz
O G
OG
Laftavi
M R
MR
Kumar
A M
AM
Damask
A M
AM
Vora
M
M
Tomeny
M B
MB
Ferry
E
E
Samartino
B C
BC
Sierka
D
D
Lingaraju
R M
RM
Fyfe
B
B
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077552:Basiliximab; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins; D013997:Time Factors
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D016572:Cyclosporine; D000077552:Basiliximab; D003404:Creatinine; D009173:Mycophenolic Acid; D011241:Prednisone